Association of C-Reactive Protein and Microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)

American Journal of Cardiology

Volumn 101, Issue 3, 2008, Pages 401-406

  Kshirsagar, Abhijit V ^a   Bomback, Andrew S ^a   Bang, Heejung ^c   Gerber, Linda M ^c   Vupputuri, Suma ^a,b   Shoham, David A ^a,c   Mazumdar, Madhu ^c   Ballantyne, Christie M ^d   Paparello, James J ^e   Klemmer, Philip J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEALTH SURVEY; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT;

ALBUMINURIA; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS;

EID: 38749097376     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.08.041     Document Type: Article

References (25)

1. Schalkwijk C.G., Poland D.C., van Dijk W., Kok A., Emeis J.J., Drager A.M., Doni A., van Hinsbergh V.W., and Stehouwer C.D. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 42 (1999) 351-357
2. Yeun J.Y., Levine R.A., Mantadilok V., and Kaysen G.A. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
3. Jager A., van Hinsbergh V.W., Kostense P.J., Emeis J.J., Nijpels G., Dekker J.M., Heine R.J., Bouter L.M., and Stehouwer C.D. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vasc Biol 22 (2002) 593-598
4. Paisley K.E., Beaman M., Tooke J.E., Mohamed-Ali V., Lowe G.D., and Shore A.C. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 63 (2003) 624-633
5. Stam F., van Guldener C., Schalkwijk C.G., ter Wee P.M., Donker A.J., and Stehouwer C.D. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18 (2003) 892-898
6. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 58 (2000) 1703-1710
7. Nakamura M., Onoda T., Itai K., Ohsawa M., Satou K., Sakai T., Segawa T., Sasaki J., Tonari Y., Hiramori K., and Okayama A. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 43 (2004) 919-925
8. Stuveling E.M., Hillege H.L., Bakker S.J., Asselbergs F.W., de Jong P.E., Gans R.O., and de Zeeuw D. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 172 (2004) 107-114
9. Stuveling E.M., Bakker S.J., Hillege H.L., Burgerhof J.G., de Jong P.E., Gans R.O., and de Zeeuw D. C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 43 (2004) 791-796
10. Stuveling E.M., Hillege H.L., Bakker S.J., Gans R.O., De Jong P.E., and De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63 (2003) 654-661
11. Wald A. Tests of statistical hypotheses concerning several parameters when the number of observations is large. Trans Am Mathematical Soc 54 (1943) 426-482
12. Harrell F.E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis (2001), Springer, New York
13. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
14. Mattix H.J., Hsu C.Y., Shaykevich S., and Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 13 (2002) 1034-1039
15. An A., and Watts D. New SAS procedures for analysis of sample survey data. SAS Users Group International (1998) 23
16. Analytic and reporting guidelines: The National Health and Nutrition Examination Survey (NHANES). http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/nhanes_analytic_guideli nes_dec_2005.pdf Accessed October 23, 2007
17. de Zeeuw D., Parving H.H., and Henning R.H. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 17 (2006) 2100-2105
18. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., Shahinfar S., Snapinn S., Cooper M.E., Mitch W.E., and Brenner B.M. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110 (2004) 921-927
19. Paul A., Ko K.W., Li L., Yechoor V., McCrory M.A., Szalai A.J., and Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109 (2004) 647-655
20. Verma S., Kuliszewski M.A., Li S.H., Szmitko P.E., Zucco L., Wang C.H., Badiwala M.V., Mickle D.A., Weisel R.D., Fedak P.W., Stewart D.J., and Kutryk M.J. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (2004) 2058-2067
21. Blann A.D., and Lip G.Y. Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells. Blood Coagul Fibrinolysis 14 (2003) 335-340
22. Nilsson J. CRP-marker or maker of cardiovascular disease?. Arterioscler Thromb Vasc Biol 25 (2005) 1527-1528
23. Vervoort G., Wetzels J.F., Lutterman J.A., Bravenboer B., Berden J.H., and Smits P. Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients. Am J Kidney Dis 40 (2002) 9-15
24. Shestakova M.V., Jarek-Martynowa I.R., Ivanishina N.S., Kuharenko S.S., Yadrihinskaya M.N., Aleksandrov A.A., and Dedov I.I. Role of endothelial dysfunction in the development of cardiorenal syndrome in patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 68 Suppl 1 (2005) S65-S72
25. Ochodnicky P., Henning R.H., van Dokkum R.P., and de Zeeuw D. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. J Cardiovasc Pharmacol 47 Suppl 2 (2006) S151-S162 discussion S172-S176.